Swiss drugmaker Roche said on Thursday that Avastin had been approved in Europe for the treatment of women with metastatic breast cancer.
The European Commission had approved Avastin for the first line treatment of women with metastatic breast cancer in combination with paclitaxel, Roche said in a statement.
No comments:
Post a Comment